Hillsdale Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-164,800
| Closed | -$1.07M | – | 655 |
|
|
2024
Q2 | $1.07M | Sell |
164,800
-6,400
| -4% | -$41.7K | 0.08% | 215 |
|
|
2024
Q1 | $1.49M | Buy |
171,200
+13,800
| +9% | +$120K | 0.12% | 192 |
|
|
2023
Q4 | $1.8M | Buy |
+157,400
| New | +$1.8M | 0.15% | 189 |
|
|
2023
Q3 | – | Sell |
-424,017
| Closed | -$4.51M | – | 610 |
|
|
2023
Q2 | $4.51M | Buy |
424,017
+3,400
| +0.8% | +$36.2K | 0.41% | 78 |
|
|
2023
Q1 | $4.42M | Hold |
420,617
| – | – | 0.38% | 94 |
|
|
2022
Q4 | $5.21M | Buy |
420,617
+1,700
| +0.4% | +$21.1K | 0.44% | 61 |
|
|
2022
Q3 | $4.34M | Buy |
418,917
+84,400
| +25% | +$874K | 0.39% | 91 |
|
|
2022
Q2 | $3.86M | Sell |
334,517
-2,000
| -0.6% | -$23.1K | 0.31% | 122 |
|
|
2022
Q1 | $4.23M | Sell |
336,517
-3,100
| -0.9% | -$39K | 0.27% | 128 |
|
|
2021
Q4 | $3.96M | Sell |
339,617
-1,000
| -0.3% | -$11.7K | 0.27% | 132 |
|
|
2021
Q3 | $4.45M | Buy |
340,617
+38,000
| +13% | +$496K | 0.34% | 96 |
|
|
2021
Q2 | $3.9M | Hold |
302,617
| – | – | 0.31% | 114 |
|
|
2021
Q1 | $3.38M | Buy |
+302,617
| New | +$3.38M | 0.28% | 126 |
|
|
2013
Q3 | – | Sell |
-5,492
| Closed | -$46K | – | 542 |
|
|
2013
Q2 | $46K | Buy |
+5,492
| New | +$46K | 0.02% | 436 |
|